BM-ca
/ Institute of Immunology
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 30, 2019
B Cell Maturation Antigen（BMCA）-Targeted CAR-T for Refractory/Relapsed Multiple Myeloma
(clinicaltrials.gov)
- P2; N=30; Recruiting; Sponsor: First Affiliated Hospital of Zhejiang University
New P2 trial
1 to 1
Of
1
Go to page
1